ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Lorenzo Spaggiari
Jean-François Regnard
Pierre Magdeleinat
Philippe Levasseur
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spaggiari, L.
Right arrow Articles by Levasseur, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spaggiari, L.
Right arrow Articles by Levasseur, P.

Ann Thorac Surg 2000;69:233-236
© 2000 The Society of Thoracic Surgeons

Original Articles

Extended resections for bronchogenic carcinoma invading the superior vena cava system

Lorenzo Spaggiari, MD, PhDa, Jean-François Regnard, MDa, Pierre Magdeleinat, MDa, Bertrand Jauffret, MDa, Philippe Puyo, MDa, Philippe Levasseur, MDa

a Department of Thoracic Surgery, Marie Lannelongue Hospital, Le Plessis Robinson, Paris, France

Address reprint requests to Dr Regnard, Department of Thoracic Surgery, Marie Lannelongue Hospital, 133 av de la Résistance, 92350, Le Plessis Robinson, Paris, France

Background. Extended resection of non-small-cell lung cancer (NSCLC) involving the superior vena cava (SVC) system is infrequently performed and oncologic benefits are still uncertain.

Methods. From 1983 to 1996, 25 patients underwent resection of the SVC system for T4, NSCLC.

Results. A total of 12 pneumonectomies (48%), ten lobectomies (40%), and three wedge resections (12%) were performed. Seven patients had complete resection of the SVC with graft interposition, 12 patients underwent tangential resection of the SVC, and 1 patient had a pericardial patch; 5 patients underwent resection of right innominate and subclavian veins without vessel reconstruction. The lymph node status was N0 in 8 patients (32%), N1 in 3 (12%) and N2 in 14 patients (56%). Five patients (20%) underwent incomplete resection. Nine patients (36%) developed postoperative complications (36%) that were fatal in 3 patients (12%). At the completion of the study, 10 patients were still alive. The median survival was 11.5 months and the 5-year actuarial survival rate was 29%, with 4 patients alive at 5 years.

Conclusions. The resection of the SVC system for direct involvement by T4, NSCLC can be performed in selected patients with an acceptable postoperative mortality. Even though no significant prognostic factors were observed, the patients who required a lobectomy with limited lymph node involvement seemed to benefit the most from surgery.




This article has been cited by other articles:


Home page
 Eur J Cardiothorac SurgHome page
F. Leo, R. Bellini, B. Conti, V. Delledonne, L. Tavecchio, and U. Pastorino
Superior vena cava resection in thoracic malignancies: does prosthetic replacement pose a higher risk?
Eur J Cardiothorac Surg, April 1, 2010; 37(4): 764 - 769.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Lanuti, P. E. De Delva, H. A. Gaissert, C. D. Wright, J. C. Wain, J. S. Allan, D. M. Donahue, and D. J. Mathisen
Review of Superior Vena Cava Resection in the Management of Benign Disease and Pulmonary or Mediastinal Malignancies
Ann. Thorac. Surg., August 1, 2009; 88(2): 392 - 397.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Borri, F. Leo, G. Veronesi, P. Solli, D. Galetta, R. Gasparri, F. Petrella, P. Scanagatta, D. Radice, and L. Spaggiari
Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results.
J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1266 - 1272.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. Spaggiari, F. Leo, G. Veronesi, P. Solli, D. Galetta, B. Tatani, F. Petrella, and D. Radice
Superior Vena Cava Resection for Lung and Mediastinal Malignancies: A Single-Center Experience With 70 Cases
Ann. Thorac. Surg., January 1, 2007; 83(1): 223 - 230.
[Abstract] [Full Text] [PDF]

Home page
 Interact CardioVasc Thorac SurgHome page
Y. Sekine, K. Yasufuku, S. Motohashi, and T. Fujisawa
Triple reconstruction of pulmonary artery, superior vena cava and bronchus for lung cancer
Interact CardioVasc Thorac Surg, August 1, 2006; 5(4): 509 - 510.
[Abstract] [Full Text] [PDF]

Home page
 MMCTSHome page
L. Spaggiari, F. Petrella, F. Leo, G. Veronesi, P. Solli, A. Borri, D. Galetta, R. Gasparri, and P. Scanagatta
Superior vena cava resection for lung and mediastinal malignancies
MMCTS, January 1, 2006; 2006(1009): mmcts.2005.001511 - mmcts.2005.001511.
[Abstract] [Full Text] [PDF]

Home page
 Interact CardioVasc Thorac SurgHome page
J. Klein, V. Kral, T. Bohanes, and M. Herman
Five-year survival after sleeve pneumonectomy combined with the superior vena cava replacement for lung cancer
Interact CardioVasc Thorac Surg, August 1, 2005; 4(4): 319 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. A. DiPerna and D. E. Wood
Surgical Management of T3 and T4 Lung Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 5038s - 5044s.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
C. C. M. Pitz, A. B. de la Riviere, H. A. van Swieten, C. J. J. Westermann, J.-W. J. Lammers, and J. M. M. van den Bosch
Results of surgical treatment of T4 non-small cell lung cancer
Eur J Cardiothorac Surg, December 1, 2003; 24(6): 1013 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
L. Spaggiari, P. Thomas, P. Magdeleinat, H. Kondo, G. Rollet, J. F. Regnard, R. Tsuchiya, and U. Pastorino
Superior vena cava resection with prosthetic replacement for non-small cell lung cancer: long-term results of a multicentric study
Eur J Cardiothorac Surg, June 1, 2002; 21(6): 1080 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
H. S. Hofmann, C. Taege, C. Lautenschlager, H. Neef, and R. E. Silber
Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer
Eur J Cardiothorac Surg, April 1, 2002; 21(4): 606 - 610.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
C. Doddoli, G. Rollet, P. Thomas, O. Ghez, Y. Seree, R. Giudicelli, and P. Fuentes
Is lung cancer surgery justified in patients with direct mediastinal invasion?
Eur J Cardiothorac Surg, August 1, 2001; 20(2): 339 - 343.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
A. Bernard, O. Bouchot, O. Hagry, and J. P. Favre
Risk analysis and long-term survival in patients undergoing resection of T4 lung cancer
Eur J Cardiothorac Surg, August 1, 2001; 20(2): 344 - 349.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. Spaggiari and U. Pastorino
Combined tracheal sleeve and superior vena cava resections for non-small cell lung cancer
Ann. Thorac. Surg., October 1, 2000; 70(4): 1172 - 1175.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.